Curaleaf says it does not comment on market speculation amid reports it may be interested in Cronos

  • 📰 MarketWatch
  • ⏱ Reading Time:
  • 24 sec. here
  • 2 min. at publisher
  • 📊 Quality Score:
  • News: 13%
  • Publisher: 97%

Россия Новости Новости

Россия Последние новости,Россия Последние новости

Curaleaf Holdings Inc. said Friday that it does not comment on market speculation after reports suggested it may be involved in a transaction. “The Company...

Curaleaf Holdings Inc. CURLF said Friday that it does not comment on market speculation after reports suggested it may be involved in a transaction. “The Company does not intend to make further comment unless required by law,” Curaleaf said in a statement. Reuters reported late Thursday that Canadian cannabis company Cronos Inc. CRON CA:CRON was working with a financial adviser to review offers and that Curaleaf Holdings was among the potential buyers.

... Curaleaf Holdings Inc. CURLF said Friday that it does not comment on market speculation after reports suggested it may be involved in a transaction. “The Company does not intend to make further comment unless required by law,” Curaleaf said in a statement. Reuters reported late Thursday that Canadian cannabis company Cronos Inc. CRON CRON was working with a financial adviser to review offers and that Curaleaf Holdings was among the potential buyers.

 

Спасибо за ваш комментарий. Ваш комментарий будет опубликован после проверки
Мы обобщили эту новость, чтобы вы могли ее быстро прочитать.Если новость вам интересна, вы можете прочитать полный текст здесь Прочитайте больше:

 /  🏆 3. in RU

Россия Последние новости, Россия Последние новости

Similar News:Вы также можете прочитать подобные новости, которые мы собрали из других источников новостей

Cronos Group stock rises in premarket as it confirms merger talksCronos Group Inc. stock is up nearly 6% in premarket trades on Friday after the Canadian cannabis company said it’s reviewing unsolicited indications of...
Источник: MarketWatch - 🏆 3. / 97 Прочитайте больше »

Bed Bath & Beyond investors have spent $200 million trading 'worthless' shares — will this holding company help them?Bed Bath & Beyond investors have spent $200 million trading ‘worthless’ shares — will this holding company help them?
Источник: MarketWatch - 🏆 3. / 97 Прочитайте больше »